The upregulated expression of COVID-19 signature genes COL10A1/FAP/FN1 are potential diagnostic targets for PC, and FN1 may affect apoptosis and other processes through activation of PI3K-AKT signaling pathway to promote PC progression. This evidence concerns the gene AKT1 and pachyonychia congenita.